146 related articles for article (PubMed ID: 16198828)
1. Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease?
Groves AM; Warren RM; Godward S; Rajan PS
Magn Reson Imaging; 2005 Jul; 23(6):733-8. PubMed ID: 16198828
[TBL] [Abstract][Full Text] [Related]
2. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
3. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
4. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
5. Breast MRI of pure ductal carcinoma in situ: sensitivity of diagnosis and influence of lesion characteristics.
Baur A; Bahrs SD; Speck S; Wietek BM; Krämer B; Vogel U; Claussen CD; Siegmann-Luz KC
Eur J Radiol; 2013 Oct; 82(10):1731-7. PubMed ID: 23743052
[TBL] [Abstract][Full Text] [Related]
6. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
8. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
[TBL] [Abstract][Full Text] [Related]
10. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.
Neubauer H; Li M; Kuehne-Heid R; Schneider A; Kaiser WA
Br J Radiol; 2003 Jan; 76(901):3-12. PubMed ID: 12595319
[TBL] [Abstract][Full Text] [Related]
11. MRI morphological classification of ductal carcinoma in situ (DCIS) correlating with different biological behavior.
Liu H; Peng W
Eur J Radiol; 2012 Feb; 81(2):214-7. PubMed ID: 21296513
[TBL] [Abstract][Full Text] [Related]
12. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings.
Mariano MN; van den Bosch MA; Daniel BL; Nowels KW; Birdwell RL; Fong KJ; Desmond PS; Plevritis S; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
J Magn Reson Imaging; 2005 Oct; 22(4):520-6. PubMed ID: 16142701
[TBL] [Abstract][Full Text] [Related]
14. Pure ductal carcinoma in situ: a range of MRI features.
Raza S; Vallejo M; Chikarmane SA; Birdwell RL
AJR Am J Roentgenol; 2008 Sep; 191(3):689-99. PubMed ID: 18716095
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
16. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
[TBL] [Abstract][Full Text] [Related]
17. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast.
Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Weyler J; Verslegers I; Biltjes I; De Schepper A; Parizel PM
JBR-BTR; 2005; 88(5):225-32. PubMed ID: 16302331
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
[TBL] [Abstract][Full Text] [Related]
19. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.
Goto M; Yuen S; Akazawa K; Nishida K; Konishi E; Kajihara M; Shinkura N; Yamada K
Eur Radiol; 2012 Jun; 22(6):1255-64. PubMed ID: 22205445
[TBL] [Abstract][Full Text] [Related]
20. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
Tozaki M
Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]